CVS Health reportedly seeking to acquire Oak Street Health for $10B

Amy Baxter | | Health Exec | Mergers & Acquisitions

CVS Health is exploring a sale of Oak Street Health, a primary care provider for Medicare patients, in a deal that could fetch $10 billion. The news was first reported by Bloomberg, which cited people familiar with the matter.

Currently, talks are ongoing between the two companies. The $10 billion figure also includes Oak Street Health’s debt, and the company currently has a market value of $5.5 billion. Oak Street operates 169 centers in the United States, caring for 159,000 patients. According to Bloomberg, private equity firms General Atlantic and Newlight Partners collectively own roughly 39% of Oak Street Health.

The purported deal comes after CVS Health, which operates nearly 10,000 retail pharmacy stores, announced in 2022 it would acquire home healthcare company Signify Health for $8 billion. That deal is expected to close in the first half of 2023. Both deals move CVS Health, which also owns health insurer Aetna, squarely into the healthcare services provider field. The retail pharmacy chain has operated clinics within its stores for many years, but its recent massive acquisitions will extend the brand’s reach in the type of services offered.

The news also comes just after Oak Street Health appointed its first-ever chief wellness officer, creating the position to support provider wellness. Oak Street Health’s provider strategy includes a high-touch approach with patients.

See the full story below:

CVS Is Exploring a $10 Billion-Plus Acquisition of Oak Street Health

Related Content

Movers & Shakers: Rite Aid CEO departs, Oak Street Health taps new officer role
CVS enters $8B agreement to acquire Signify Health
Amazon in the mix to bid on Signify Health
Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

FDA approves first therapy for very rare lipid storage disorder
Report: Johnson & Johnson wants to sell its stroke business for more than $1B
Zimmer agrees to buy Paragon 28 for $1.1B
Concerns about private equity's growing influence in radiology
Philips to sell its emergency care business to private equity firm
FTC, DOJ and HHS release report warning of private equity consolidation in healthcare

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”